Contact
DMCA
Privacy
Robuta
https://www.technologynetworks.com/drug-discovery/news/bioasis-enters-into-a-license-agreement-with-medimmune-188097
biOasis Enters into a License Agreement with MedImmune | Technology Networks
Agreement for second generation versions of biOasis's Transcend.
license agreement
enters
medimmune
technology
networks
https://www.nndb.com/company/995/000125620/
MedImmune
medimmune
https://www.biospace.com/medimmune-inc-chairman-and-founder-receives-leadership-excellence-award-from-robert-h-smith-school-of-business
MedImmune, Inc. Chairman And Founder Receives Leadership Excellence Award From Robert H. Smith...
leadership excellence award
medimmune inc
chairman
founder
receives
https://www.biospace.com/medimmune-inc-expands-patent-estate-for-reverse-genetics-with-new-rights-from-mount-sinai-school-of-medicine
MedImmune, Inc. Expands Patent Estate For Reverse Genetics With New Rights From Mount Sinai School...
medimmune inc
reverse genetics
expands
patent
estate
https://www.biospace.com/medimmune-inc-announces-several-management-promotions
MedImmune, Inc. Announces Several Management Promotions - BioSpace
medimmune inc
announces
several
management
promotions
https://www.fiercebiotech.com/biotech/medimmune-announces-research-collaboration-uc-san-francisco
MEDIMMUNE ANNOUNCES RESEARCH COLLABORATION WITH UC SAN FRANCISCO | Fierce Biotech
GAITHERSBURG, MD, USA I February 11, 2014 I MedImmune, the global biologics research and development arm of AstraZeneca, today announced it has entered into a...
uc san francisco
research collaboration
fierce biotech
medimmune
announces